"Helicobacter pylori" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).
| Descriptor ID |
D016480
|
| MeSH Number(s) |
B03.440.500.550 B03.660.150.280.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Helicobacter pylori".
Below are MeSH descriptors whose meaning is more specific than "Helicobacter pylori".
This graph shows the total number of publications written about "Helicobacter pylori" by people in this website by year, and whether "Helicobacter pylori" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 32 | 5 | 37 |
| 1997 | 34 | 0 | 34 |
| 1998 | 24 | 4 | 28 |
| 1999 | 34 | 8 | 42 |
| 2000 | 33 | 3 | 36 |
| 2001 | 22 | 5 | 27 |
| 2002 | 35 | 4 | 39 |
| 2003 | 30 | 1 | 31 |
| 2004 | 16 | 2 | 18 |
| 2005 | 25 | 4 | 29 |
| 2006 | 19 | 4 | 23 |
| 2007 | 16 | 3 | 19 |
| 2008 | 26 | 4 | 30 |
| 2009 | 25 | 5 | 30 |
| 2010 | 23 | 6 | 29 |
| 2011 | 24 | 5 | 29 |
| 2012 | 22 | 5 | 27 |
| 2013 | 30 | 3 | 33 |
| 2014 | 30 | 5 | 35 |
| 2015 | 33 | 5 | 38 |
| 2016 | 23 | 3 | 26 |
| 2017 | 27 | 7 | 34 |
| 2018 | 35 | 9 | 44 |
| 2019 | 23 | 6 | 29 |
| 2020 | 32 | 7 | 39 |
| 2021 | 26 | 4 | 30 |
| 2022 | 22 | 0 | 22 |
| 2023 | 29 | 0 | 29 |
| 2024 | 22 | 1 | 23 |
| 2025 | 15 | 1 | 16 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Helicobacter pylori" by people in Profiles.
-
Comparative efficacy, safety and compliance with dual, triple and quadruple therapy as the first-line treatment regimens for Helicobacter pylori eradication: a systematic review and network meta-analysis. BMJ Open Gastroenterol. 2026 Jan 14; 13(1).
-
Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study. Lancet Microbe. 2026 Jan; 7(1):101217.
-
Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial). Sci Rep. 2025 Dec 18; 15(1):44105.
-
Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. Population. Helicobacter. 2025 Nov-Dec; 30(6):e70095.
-
Seroprevalence of Helicobacter pylori Infection Among Asymptomatic Patients Served by a Safety-Net Healthcare System. Clin Gastroenterol Hepatol. 2026 May; 24(5):1289-1297.
-
Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II. Gut. 2025 Oct 08; 74(11):1767-1791.
-
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions. Gut. 2025 Sep 08; 74(10):1561-1570.
-
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected Adults. Helicobacter. 2025 Sep-Oct; 30(5):e70064.
-
Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric Microbiome. Helicobacter. 2025 Sep-Oct; 30(5):e70072.
-
Controversies in management of Helicobacter pylori infection from a U.S. perspective: population screening and treatment. Minerva Gastroenterol (Torino). 2025 Sep; 71(3):194-206.